UK markets closed

MyMD Pharmaceuticals, Inc. (MYMD)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.3300+0.0900 (+2.78%)
At close: 04:00PM EDT
3.2692 -0.06 (-1.83%)
After hours: 07:03PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Cost of revenue
0
0
0
0
0
Gross profit
0
0
0
0
0
Operating expenses
Research development
7,323
7,868
9,067
6,745
2,467
Selling general and administrative
7,277
8,492
6,215
21,456
5,811
Total operating expenses
14,601
16,360
15,283
28,201
8,296
Operating income or loss
-14,601
-16,360
-15,283
-28,201
-8,296
Interest expense
-92.63
-
0
608.46
1,192
Total other income/expenses net
-206.363
11,905
1.436
-1,088
-
Income before tax
-14,692
-4,000
-15,197
-29,889
-9,488
Income tax expense
0
0
0
0
0
Income from continuing operations
-14,692
-4,000
-15,197
-29,889
-9,488
Net income
-14,692
-4,000
-15,197
-29,889
-9,488
Net income available to common shareholders
-14,692
-8,218
-15,197
-29,889
-9,488
Basic EPS
-5.10
-5.33
-11.74
-25.50
-7.66
Diluted EPS
-5.10
-5.33
-11.74
-25.50
-7.66
Basic average shares
1,374
1,542
1,294
1,167
1,238
Diluted average shares
1,374
1,542
1,294
1,167
1,238